Alnylam Gets VIP Status as the FDA Slaps Breakthrough Tag on Patisiran Post author:Sam Post published:November 19, 2017 Post category:BioPharma The company is weeks away from completing its rolling NDA for Patisiran. Source: BioSpace You Might Also Like <b>Protonics</b> T2 Exo: Strength + Speed + Agility – Pain February 16, 2017 Future Biotech Giants: 11 Life Science Entrepreneurs Under 30 February 22, 2017 Galectin Tanks as NASH Drug Flunks Phase IIb Trial December 4, 2017
